$BLUE: Bluebird Bio’s Competitive Advantage Is Underappreciated …

Date: Thursday, December 20th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: Bluebird bio, Inc, (NASDAQ: BLUE) has built a gene therapy platform with which the company genetically alters patient cells under laboratory conditions and …

Full article address: https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12882189/bluebird-bios-competitive-advantage-is-underappreciated

Related News:

$SOLO $CUZ $SPR $BLUE: Report: Exploring Fundamental Drivers Behind Tyson Foods …

$BLUE: bluebird bio Appoints Chip Baird as Chief Financial Officer

$BLUE: Where Will bluebird bio Be in 5 Years?

$BLUE: Here’s What Pushed bluebird bio Stock Down 44.3% in 2018

$SRPT $BLUE $VRTX: 3 Biotech Stocks to Watch in 2019

$BLUE $CI $NOVN.EB $ONCE: Biotech Proposes Paying for Pricey Drugs by Installment

$BLUE: bluebird bio to Present at the 37th Annual JP Morgan Healthcare …

$BLUE: EQUITY ALERT: Rosen Law Firm Announces Investigation of …

$BLUE: Robbins Arroyo LLP: bluebird bio, Inc. (BLUE) Misled Shareholders …

$BLUE: Forget bluebird bio, Amgen Is a Better Biotech Stock

$BLUE: Glancy Prongay & Murray LLP Announces Investigation on Behalf of …

Latest News:

$WIN $TTC: Earnings Scheduled For February 21, 2019

$ET: Energy Transfer Posts Tremendous Growth, But At A Cost

$BCS: Barclays Tops FTSE 100 After CEO Pledges Shareholder Returns Amid Activist Fight

$HD: Home Depot Pros And Cons

$INFY: Infosys Recognized Among the Top Three Employers in Europe and …

$JNJ: Johnson & Johnson receives federal subpoenas

$NTES: NetEase (NTES) Q4 2018 Earnings Conference Call Transcript

$MCD $DIS: YouTube ads pulled over exploitation fears

$TK: Teekay Corporation Reports Fourth Quarter and Annual 2018 Results

$TNK: Teekay Tankers Ltd. Reports Fourth Quarter and Annual 2018 Results

$TGP: Teekay LNG Partners Reports Fourth Quarter 2018 and Annual …